Oral delivery of Non-Absorbed Biomolecules to the GI tract
3/22/2022 11:50 - 12:20
A knowledge-based strategy for understanding and optimising the delivery of biomolecules for local activity in the human GI tract, including microbiome, bacterial therapeutics, enzymes, vaccines and monoclonal antibodies.
Fiona is Director of Biopharmaceutics at BDD. A registered pharmacist, she has more than 20 years’ experience in formulation development, with a focus on controlled release and chronotherapeutics. Fiona has extensive expertise in vivo evaluation of novel formulations. Through her work in this area, she has gained an in depth understanding of how different formulations will perform in man which she uses to guide intelligent formulation design. Fiona has a PhD and degree in Pharmacy from the University of Strathclyde.